RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

A neural network model improves time-lapse super-resolution ... fluorescent biosensor allows real-time visualization of PKN kinase activity, revealing sustained activity at the plasma membrane ...

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

Network models are a computer architecture, implementable in either hardware or software, meant to simulate biological populations of interconnected neurons. These models, also known as ...

Mexico Reaches Deal With U.S. to Delay Trump Tariffs President Trump said he would pause tariffs on Mexico for a month, but levies on Canada and China were still set to take effect on Tuesday ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

Two scientists from the UK received Thailand's Prince Mahidol Awards for 2024 for long and significant contribution in the ...

This important study provides new evidence on the role of norepinephrine (NE) release in the hippocampus in response to environmental transitions (event boundaries), providing a potential link between ...

Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...

Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a chronic inflammatory skin condition of the skin, hair, nails, mouth and ...